Comprehensive Metabolic Panel Reference Ranges

Back To: Clinician on FHIR - May 2017 Madrid, Spain

• University of Rochester Medical Centre Metabolic Panel:

- Glucose test: less than 110 mg/dL; (3.55 to 5.55 mmol/L)

- Albumin: 3.5 to 5.0 grams per deciliter (g/dL)

- Total protein: 6.4 to 8.3 g/dL

- BUN: 10 to 20 milligram/per deciliter (mg/dL); (2.50 to 7.14 mmol/L)

- Creatinine: 0.5 to 1.1 mg/dL (females), 0.6 to 1.2 mg/dL (males)

- Potassium test: 3.5 to 5.0 milliequivalents per liter (mEq/L); (3.7 to 5.2 mmol/L)

- Sodium: 136 to 145 mEq/L; (136 to 144 mmol/L)

- Chloride: 96 to 106 mmol/L

- Carbon dioxide: 23 to 30 millimoles per liter (mmol/L)

- ALP (alkaline phosphatase): 30 to 120 international units/liter (IU/L)

- ALT (alanine amino transferase): 4 to 36 IU/L

- AST (aspartate amino transferase): 0 to 35 IU/L

- Calcium: 9.0 to 10.5 mg/dL

- Total bilirubin: 0.3 to 1.0 mg/dL

• eGFR (source: Australia Kidney Foundation):

Stage 1: A normal eGFR greater than or equal to 90 mL/min/1.73m^2

Stage 2: Slightly decreased eGFR between 60–89 mL/min/1.73m^2

Stage 3a: Mild–moderate decrease in eGFR between 45–59 mL/min/1.73m^2

Stage 3b: Moderate–severe decrease in eGFR between 30–44 mL/min/1.73m^2

Stage 4: Severe decrease in eGFR between 15–29 mL/min/1.73m^2

Stage 5: Kidney failure as eGFR decreases to less than 15 mL/min/1.73m^2 or dialysis is started